BEPP hydrochloride
Based on 1 Customer Validation
BEPP hydrochloride is a double-stranded RNA-dependent protein kinase (PKR) modulator. BEPP hydrochloride enhances the phosphorylation levels of PKR and eIF2α, activates caspase-3, upregulates the pro-apoptotic protein BAX, and downregulates the anti-apoptotic protein Bcl-2. BEPP hydrochloride inhibits vaccinia virus replication and exhibits selective cytotoxicity in cells expressing PKR. BEPP hydrochloride can be used in research related to cancer and viral infections.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.62%
- CAS No.: 455311-98-5
- Formule: C23H24ClN3O2
- Masse moléculaire:409.91
-
Stockage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Voir tous les produits spécifiques à Isoform Caspase
More
Activité biologique
Description
In Vitro
BEPP (1-100 μM; 1-5 days) hydrochloride potently inhibits the growth of MEF/PKR (+/+) cells with an IC50 of 1.4 μM, and its efficacy is 10-fold that against MEF/PKR (-/-) cells[1].
BEPP (2.5-10 μM; 72 h) hydrochloride induces apoptosis-related caspase-3 cleavage, upregulation of BAX expression, and downregulation of Bcl-2 expression in MEF/PKR (+/+) cells, but exerts no such effects on MEF/PKR (-/-) cells[1].
BEPP (2.5-10 μM; 72 h) hydrochloride activates the PKR pathway in MEF/PKR (+/+) cells, increases the levels of phosphorylated PKR and eIF2α, reduces the level of cyclin D1, and elevates the level of phosphorylated AKT, but fails to activate eIF2α in MEF/PKR (-/-) cells[1].
BEPP (2.5-10 μM; 24-72 h) hydrochloride induces apoptosis in MEF/PKR (+/+) cells in a dose- and time-dependent manner, while MEF/PKR (-/-) cells show no significant apoptotic response[1].
BEPP (0.3-100 μM; 72 h) hydrochloride potently inhibits the growth of H226B human lung cancer cells overexpressing PKR, with an IC50 of 4.6 μM, and its inhibitory activity is stronger than that against H460, A549, H1299 and HBE cells[1].
BEPP (7.5 μM; 48 h pretreatment) hydrochloride reduces the replication level of vaccinia virus (vSP) in HeLa cells by approximately 100-fold, and induces activation of the PKR pathway, as evidenced by increased levels of phosphorylated PKR and eIF2α[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:mouse embryonic fibroblast wild-type [MEF/PKR(+/+)], PKR-knockout [MEF/PKR(-/-)] cells
-
Concentration:1-100 μM (72 h incubation); 2.5 μM (1, 3, 5 days incubation)
-
Incubation Time:72 h (1, 5, 10, 25, 50, 100 μM); 1, 3, 5 days (2.5 μM)
-
Result:Suppressed the growth of MEF/PKR(+/+) cells more effectively than MEF/PKR(-/-) cells.
Killed MEF/PKR(+/+) cells with an IC50 value of 1.4 μM, whereas its IC50 value on MEF/PKR(-/-) cells was approximately 17.4 μM.
-
Cell Line:MEF/PKR(+/+), MEF/PKR(-/-) cells
-
Concentration:2.5-10 μM (72 h incubation); 10 μM (24, 72 h incubation)
-
Incubation Time:72 h (2.5, 5, 10 μM); 24, 72 h (10 μM)
-
Result:Increased sub-G1 phase MEF/PKR(+/+) cells to 32.3% after 24 h treatment with 10 μM, and to 84.6% after 72 h.
Caused dramatic increases in sub-G1 MEF/PKR(+/+) cells at doses of 5 and 10 μM for 72 h.
Resulted in less than 5% sub-G1 cells in MEF/PKR(-/-) cells under all tested conditions.
-
Cell Line:human lung cancer cell lines (H226B, H460, A549, H1299), human bronchial epithelial (HBE) cells
-
Concentration:0.3, 1.0, 3.3, 10.0, 33.3, 100 μM
-
Incubation Time:72 h
-
Result:Inhibited growth of all five cell lines in a dose-dependent manner.
Achieved IC50 values at 72 h of 4.6 μM for H226B, 11.5 μM for H460, 13.8 μM for A549, 15.8 μM for H1299, and 15.6 μM for HBE.
Showed highest potency against H226B cells, which had higher PKR expression than the other cell lines.
Chemical Information
-
CAS No. 455311-98-5
-
Appearance Solid
-
Masse moléculaire 409.91
-
Formule C23H24ClN3O2
-
Color White to off-white
-
SMILES
OC(COC1=CC=CC=C1)CN2C3=CC=CC=C3N(CC4=CC=CC=C4)C2=N.Cl
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvant et solubilité
In Vitro:
DMSO : 4.17 mg/mL (10.17 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocole
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
-
Fiche technique (279 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.4396 mL | 12.1978 mL | 24.3956 mL | 60.9890 mL |
| 5 mM | 0.4879 mL | 2.4396 mL | 4.8791 mL | 12.1978 mL | |
| 10 mM | 0.2440 mL | 1.2198 mL | 2.4396 mL | 6.0989 mL |